Correspondence 0001104659-24-056958 from Solana Co (HSDT)
Solana Co
Date: May 3, 2024 · CIK: 0001610853 · Accession: 0001104659-24-056958
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278698
Letter
Re: Helius Medical Technologies, Inc.
May 3, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Benjamin Richie
Registration Statement on Form S-1
File No. 333-278698
Acceleration Request
Requested Date: May 6,
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (File No. 333-278698) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes Emily Johns of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness of the Registration Statement with Emily Johns of Honigman LLP by telephone at (616) 649-1908.
[Signature page follows]
****
Sincerely,
Helius Medical Technologies, Inc.
Show Raw Text
CORRESP
1
filename1.htm
May 3, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Benjamin Richie
Re: Helius
Medical Technologies, Inc.
Registration Statement on Form S-1
File No. 333-278698
Acceleration Request
Requested Date: May 6,
2024
Requested Time: 5:00
P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the “Company”) hereby respectfully
requests that the above-referenced Registration Statement on Form S-1 (File No. 333-278698) (the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable
thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of
Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes Emily Johns of Honigman LLP, counsel to the
Company, to make such request on its behalf.
Please confirm the effectiveness
of the Registration Statement with Emily Johns of Honigman LLP by telephone at (616) 649-1908.
[Signature page follows]
****
Sincerely,
Helius Medical Technologies, Inc.
/s/ Dane C. Andreeff
Dane C. Andreeff
President and Chief Executive Officer
cc: Emily
Johns, Honigman LLP